Multi-Transcriptome-Informed Network Pharmacology Reveals Novel Biomarkers and Therapeutic Candidates for Parkinson's Disease. [PDF]
Pappu MAA +11 more
europepmc +1 more source
The Clinical Implications of Ashwagandha (<i>Withania somnifera</i> L.) with a Special Reference to Side Effects-A Review. [PDF]
Winther K.
europepmc +1 more source
Integrative In Silico Multi-Omics Profiling of circRNA-Mediated ceRNA Networks Reveals Prognostic Biomarkers and Repurposed Therapeutic Candidates in Gastric Cancer. [PDF]
Bakirci ME, Aydin B.
europepmc +1 more source
Exploratory Covalent Docking of Michael-Acceptor Natural Products at Reactive Cysteines in Cancer Tyrosine Kinases. [PDF]
Lobo F +5 more
europepmc +1 more source
Superior Bioavailability of a Novel 1.5% Ashwagandha Formulation (Zenroot™): A Randomized, Double-Blind, Single-Dose, Comparative, Oral Bioavailability Study in Healthy Adults. [PDF]
Ramapalaniappan A +6 more
europepmc +1 more source
Toxicological evaluation of herbo-mineral formulation: Acute and sub-acute oral toxicity in rats. [PDF]
Tambe MS, Baheti AM, Swami AG, Pawar AT.
europepmc +1 more source
Jidongwangia sp. JTT04 as a novel bioinoculant: promoting growth and modulating the metabolic profile of Ashwagandha (Withania somnifera (L.) Dunal). [PDF]
Mohammed AE +7 more
europepmc +1 more source
Cell Surface Vimentin Is an Attachment Factor That Facilitates Equine Arteritis Virus Infection In Vitro. [PDF]
Thieulent CJ +5 more
europepmc +1 more source
Withaferin A reduces pulmonary eosinophilia and IL-25 production in a mouse model of allergic airways disease. [PDF]
Agner K +5 more
europepmc +1 more source
Deciphering Antidiabetic, Anti-Inflammatory, and Anti-Cholinergic Bioactivities of Withania somnifera (L) Dunal Root Extract: An In Vitro and In Silico Investigation. [PDF]
Mulelu L +4 more
europepmc +1 more source

